SI3139932T1 - Režim zdravljenja za spojino tiacumicina - Google Patents

Režim zdravljenja za spojino tiacumicina

Info

Publication number
SI3139932T1
SI3139932T1 SI201530443T SI201530443T SI3139932T1 SI 3139932 T1 SI3139932 T1 SI 3139932T1 SI 201530443 T SI201530443 T SI 201530443T SI 201530443 T SI201530443 T SI 201530443T SI 3139932 T1 SI3139932 T1 SI 3139932T1
Authority
SI
Slovenia
Prior art keywords
treatment regimen
tiacumicin compound
tiacumicin
compound
regimen
Prior art date
Application number
SI201530443T
Other languages
English (en)
Inventor
Andreas Johannis Karas
Christopher Mark Longshaw
Original Assignee
Astellas Pharma Europe Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Europe Ltd. filed Critical Astellas Pharma Europe Ltd.
Publication of SI3139932T1 publication Critical patent/SI3139932T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SI201530443T 2014-05-09 2015-05-11 Režim zdravljenja za spojino tiacumicina SI3139932T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14075031 2014-05-09
PCT/EP2015/000965 WO2015169451A1 (en) 2014-05-09 2015-05-11 Treatment regimen tiacumicin compound
EP15731245.5A EP3139932B1 (en) 2014-05-09 2015-05-11 Treatment regimen for tiacumicin compound

Publications (1)

Publication Number Publication Date
SI3139932T1 true SI3139932T1 (sl) 2018-12-31

Family

ID=50771031

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201530443T SI3139932T1 (sl) 2014-05-09 2015-05-11 Režim zdravljenja za spojino tiacumicina

Country Status (23)

Country Link
US (1) US10137141B2 (sl)
EP (1) EP3139932B1 (sl)
JP (1) JP6579662B2 (sl)
KR (1) KR20160149288A (sl)
AU (1) AU2015258130B2 (sl)
CA (1) CA2948400A1 (sl)
CY (1) CY1120847T1 (sl)
DK (1) DK3139932T3 (sl)
EA (1) EA031756B1 (sl)
ES (1) ES2694028T3 (sl)
GE (1) GEP20186872B (sl)
HR (1) HRP20181756T1 (sl)
IL (1) IL248782B (sl)
LT (1) LT3139932T (sl)
MA (1) MA39952B1 (sl)
MD (1) MD4695C1 (sl)
PL (1) PL3139932T3 (sl)
PT (1) PT3139932T (sl)
RS (1) RS57994B1 (sl)
SI (1) SI3139932T1 (sl)
TR (1) TR201815891T4 (sl)
UA (1) UA122203C2 (sl)
WO (1) WO2015169451A1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3316892B1 (en) * 2015-07-03 2023-07-19 Tillotts Pharma AG Novel dosage regimen of tiacumicin compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
US7507564B2 (en) 2002-07-29 2009-03-24 Optimer Pharmaceuticals, Inc. Tiacumicin production
LT2305245T (lt) * 2004-05-14 2019-03-12 Merck Sharp & Dohme Corp. Su antibiotikų vartojimu susijusių ligų gydymas
MX340742B (es) 2005-01-31 2016-07-21 Merck Sharp & Dohme Compuestos macrociclicos de 18 miembros y analogos de los mismos.
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
US20080176927A1 (en) * 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
CN102030791B (zh) 2010-10-28 2013-01-23 中国科学院南海海洋研究所 四种台勾霉素类化合物及其制备方法和在制备抗菌药物中的应用
CN102115757B (zh) 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
WO2013138748A1 (en) * 2012-03-16 2013-09-19 Optimer Pharmaceuticals, Inc. Prevention of clostridium difficile infection in high risk patients
JO3464B1 (ar) * 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين

Also Published As

Publication number Publication date
KR20160149288A (ko) 2016-12-27
CY1120847T1 (el) 2019-12-11
MA39952B1 (fr) 2018-12-31
MA39952A (fr) 2017-03-15
HRP20181756T1 (hr) 2018-12-28
LT3139932T (lt) 2018-11-12
MD20160131A2 (ro) 2017-05-31
IL248782B (en) 2020-08-31
IL248782A0 (en) 2017-01-31
RS57994B1 (sr) 2019-01-31
EP3139932A1 (en) 2017-03-15
AU2015258130A1 (en) 2016-12-15
DK3139932T3 (en) 2018-11-12
ES2694028T3 (es) 2018-12-17
EA031756B1 (ru) 2019-02-28
TR201815891T4 (tr) 2018-11-21
GEP20186872B (en) 2018-06-25
CA2948400A1 (en) 2015-11-12
MD4695B1 (ro) 2020-05-31
UA122203C2 (uk) 2020-10-12
EA201692107A1 (ru) 2017-04-28
PL3139932T3 (pl) 2019-02-28
WO2015169451A1 (en) 2015-11-12
JP2017514880A (ja) 2017-06-08
EP3139932B1 (en) 2018-08-01
PT3139932T (pt) 2018-11-14
JP6579662B2 (ja) 2019-09-25
AU2015258130B2 (en) 2019-10-31
US10137141B2 (en) 2018-11-27
MD4695C1 (ro) 2021-02-28
US20170143750A1 (en) 2017-05-25

Similar Documents

Publication Publication Date Title
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201415573D0 (en) Compounds
GB201411418D0 (en) Compounds
GB201418300D0 (en) Compounds
GB201410430D0 (en) Compounds
GB201402431D0 (en) Compounds
GB201417369D0 (en) Compounds
GB201416186D0 (en) Compounds
GB201417561D0 (en) Compounds
GB201404987D0 (en) Compounds
GB201406591D0 (en) Compounds
GB201419228D0 (en) Compounds
GB201406956D0 (en) Compounds
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201419264D0 (en) Compounds
GB201412660D0 (en) Compounds
GB201417168D0 (en) Compounds
GB201419015D0 (en) Compounds
HRP20181756T1 (hr) Režim liječenja sa spojem tiakumicina
GB201407695D0 (en) Compounds
GB201405361D0 (en) Compounds
GB201416462D0 (en) Compound for use
GB201421020D0 (en) Compounds
GB201419321D0 (en) Compounds
GB201419322D0 (en) Compounds